Item Infomation

Full metadata record
DC FieldValueLanguage
dc.contributor.authorMarius, Trøseid-
dc.contributor.authorJosé R., Arribas-
dc.contributor.authorLambert, Assoumou-
dc.date.accessioned2023-03-29T08:40:50Z-
dc.date.available2023-03-29T08:40:50Z-
dc.date.issued2023-
dc.identifier.urihttps://link.springer.com/article/10.1186/s13054-022-04205-8-
dc.identifier.urihttps://dlib.phenikaa-uni.edu.vn/handle/PNK/7298-
dc.descriptionCC BYvi
dc.description.abstractBaricitinib has shown efficacy in hospitalized patients with COVID-19, but no placebo-controlled trials have focused specifically on severe/critical COVID, including vaccinated participants.vi
dc.language.isoenvi
dc.publisherSpringervi
dc.subjectBari-SolidActvi
dc.subjectplacebo-controlled phase 3 trialvi
dc.titleEfficacy and safety of baricitinib in hospitalized adults with severe or critical COVID-19 (Bari-SolidAct): a randomised, double-blind, placebo-controlled phase 3 trialvi
dc.typeBookvi
Appears in CollectionsOER- Y học- Điều dưỡng

Files in This Item: